Tag: #Global Trends

Corxel Pharmaceuticals, a China-based biotech firm, has successfully closed a $287 million Series D1 financing round. This significant milestone will... Read more

Janux Therapeutics Inc., a clinical-stage biopharmaceutical company specializing in novel immunotherapies, has officially named William Go, M.D., Ph.D., as its... Read more

Eclipse Bioinnovations Inc. (Eclipsebio), a leading provider of sequencing-based analytics for RNA medicines, has announced the acquisition of Terrain Bio,... Read more

Recipharm, a global Contract Development and Manufacturing Organization (CDMO), has established a new, dedicated facility for non-bacterial beta-lactam medicines. This... Read more

MS Pharma Group has entered into a strategic partnership with Hetero Group to localize five established biosimilars across key therapeutic... Read more

Fortitude Biomedicines, a biopharmaceutical firm based in Waltham, Massachusetts, has officially launched following the closure of a $13 million seed... Read more

Eurofins CDMO Alphora, a member of the international Eurofins Scientific network, has announced the launch of an AI-powered software platform... Read more

A significant divide is emerging in the U.S. healthcare system as numerous states and pediatricians announce their continued adherence to... Read more

Following the remarkable success of Enhertu and Datroway, Japanese pharmaceutical giant Daiichi Sankyo is striving to solidify its leadership in... Read more